ACG makes two significant European appointments 25th May 2021
ACG, the world’s most integrated pharmaceutical supplier, appoints two senior executives in Europe. Daniel Illmer joins as design head – encapsulation, and Afsaneh Nakhavoli, as design head – tableting. Both join the company’s R&D facility in Germany.
As design head – encapsulation, Daniel Illmer will oversee product development, maintenance, improvements, redesign, and will report to Werner Bongers, CEO, SciTech, ACG. Daniel joins the ACG team from Robert Bosch Packaging Technology GmbH, where he was responsible for mechanical design, development, and engineering among other areas.
Afsaneh Nakhavoli’s new role as design head – tableting will include leading innovation and product development, with the same reporting lines. In the last seven years as a project engineer at Fette Engineering GmbH, Afsaneh led the development and construction of automatic capsule-filling machines.
Commenting on the appointments, Werner Bongers said: “I am delighted to welcome Daniel and Afsaneh to the ACG team. Design heads are pivotal to our business and their wealth of industry experience will help drive innovation and underpin the continued global growth of ACG. Their appointments follow the exciting news celebrating our recent prestigious iF Design Award win. We continue to develop and evolve as a business – working closely with our partners to drive technology in the pharmaceutical industry. Our people are integral to helping advance our mission: to make the world a healthier place.”
On being a part of ACG’s global success story, Afsaneh Nakhavoli said: “ACG stands for innovation, invention, and inclusiveness. They are one of the leaders in technology in the pharma industry. What made the move irresistible though, is the opportunity to develop high-class products with a diverse team of global experts.”
Echoing Afsaneh, Daniel Illmer added: “This is such an exciting time to join ACG, as the company advances both in Europe and globally. I am very much looking forward to further developing the ACG brand, and its new generation of pharma equipment.”